We are live on
!
Find out more
THP
Tower House Partners Portfolio holdings
AUM
$16.8M
1-Year Est. Return
41.98%
This Fund
S&P 500
This Quarter
Est. Return
-13.26%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.1M
AUM Growth
-$23.3M
(-41%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-46.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Azenta
AZTA
|
+$7.83M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$6.78M |
| 3 |
Charles River Laboratories
CRL
|
+$1.35M |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
RCGV
SCM
CCA
OHU
OA
JM
OP
AC
Tower House Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Tower House Partners held 3 positions worth $34.1M, down 41% from $57.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tower House Partners withdrew a net $16M in Q2 2022, reducing 3 holdings. Its largest reduction was Azenta, cutting an estimated $7.83M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tower House Partners's biggest Q2 2022 reduction was Azenta, cutting an estimated $7.83M.
- Tower House Partners's ten largest holdings make up 100% of its $34.1M portfolio in Q2 2022.
- Tower House Partners opened 0 new positions and closed 0 in Q2 2022.
- Tower House Partners's portfolio value fell 41% quarter-over-quarter to $34.1M.
Based on Tower House Partners's 13F filing for Q2 2022, filed 15 Aug 2022.